Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Relig Health ; 63(3): 2314-2326, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38361001

ABSTRACT

This paper examined gender (N = 1406;77.7% women) patterns of religious coping and psychological impact following the devastating 2023 Syrian earthquakes. Measures in this nation-wide convenience sample study included positive religious coping (PRC) and negative religious coping (NRC) using the Brief Religious Coping Scale (RCOPE), and probable PTSD, depression, and anxiety, using the PCL-5, PHQ-9, and GAD-7, respectively. Women reported higher endorsement of PRC items while men higher endorsement of NRC items. Within the women only sample, lower education and lower income, education and younger age predicted PRC and NRC, respectively. NRC was strongly positively associated with PTSD, depression and anxiety; while, PRC was positively associated only with PTSD. These vulnerable women require targeted support to adopt more adaptive religious coping strategies.


Subject(s)
Coping Skills , Earthquakes , Religion and Psychology , Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Anxiety/psychology , Depression/psychology , Stress Disorders, Post-Traumatic/psychology , Surveys and Questionnaires , Syria , Natural Disasters
2.
J Trauma Stress ; 31(3): 321-331, 2018 06.
Article in English | MEDLINE | ID: mdl-29958336

ABSTRACT

Adjustment disorder is a common psychiatric disorder, yet knowledge of the efficacious treatments for adjustment disorder is limited. In this systematic review, we aimed to examine psychological and pharmacological interventions that target adjustment disorder in adults to determine which interventions have the best evidence for improving adjustment disorder symptoms. We performed database searches for literature published between January 1980 and September 2016 and identified studies that included both a sample majority of individuals diagnosed with adjustment disorder and findings on adjustment disorder symptom outcomes. There were 29 studies that met the inclusion criteria for qualitative synthesis; the majority of studies (59%) investigated psychological therapies rather than pharmacological treatments (35%). The range of psychological therapies tested was diverse, with the majority containing cognitive behavioral therapy (CBT) components (53%), followed by three studies that were psychodynamic-related, three studies that were behavioral therapy-based, and two studies that involved relaxation techniques. We rated individual studies using a modified National Health and Medical Research Council quality and bias checklist and then used the Grading of Recommendations Assessment, Development and Evaluation (GRADE; Grade Working Group, 2004) system to rate the overall quality of the evidence. Despite several randomized controlled trials, the quality of the evidence for positive effects of all psychological and pharmacological treatments on symptoms of adjustment disorder was ranked as low to very low. Future high-quality research in the treatment of adjustment disorder has the potential to make a significant difference to individuals who struggle to recover after stressful events.


Subject(s)
Adjustment Disorders/therapy , Benzodiazepines/therapeutic use , Cognitive Behavioral Therapy , Hypnotics and Sedatives/therapeutic use , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adjustment Disorders/drug therapy , Adult , Anti-Anxiety Agents/therapeutic use , Antidepressive Agents/therapeutic use , Humans , Phytotherapy , Plant Extracts/therapeutic use , Psychotherapy, Psychodynamic , Relaxation Therapy
3.
Mil Med ; 2022 Nov 26.
Article in English | MEDLINE | ID: mdl-36433752

ABSTRACT

INTRODUCTION: A range of evidence-based treatments are available for PTSD. However, many veterans with PTSD do not engage in these treatments. Concurrently, various novel PTSD treatments with little or no evidence based are increasingly popular among veterans. This qualitative study explored the expectations, experiences, and perceptions of help-seeking veterans with PTSD to improve understanding of how these veterans make treatment decisions. MATERIALS AND METHODS: Fifteen treatment-seeking veterans with PTSD participated in the study. Participants took part in semi-structured interviews. Data were analyzed using interpretative phenomenological analysis. RESULTS: A number of themes and subthemes emerged from the data, providing a detailed account of the factors that influenced participants' treatment decisions. Most participants were in an acute crisis when they made the initial decision to seek treatment for their PTSD. In choosing a specific treatment, they tended to follow recommendations made by other veterans or health professionals or orders or directions from their superiors, health providers, or employers. Few participants actively considered the scientific evidence supporting different treatments. Participants had a strong preference for treatment provided by or involving other veterans. They reported finding PTSD treatments helpful, although some were not convinced of the value of evidence-based treatments specifically. Many participants reported negative experiences with treatment providers. CONCLUSIONS: These findings will inform strategies to improve engagement of veterans in evidence-based PTSD treatments and advance progress toward veteran-centered care.

4.
J Psychoactive Drugs ; 53(1): 85-95, 2021.
Article in English | MEDLINE | ID: mdl-32931403

ABSTRACT

The aim of this systematic review was to examine the efficacy of MDMA, ketamine, LSD, and psilocybin for the treatment of posttraumatic stress disorder (PTSD). A search of four databases for English language, peer-reviewed literature published from inception to 18th October 2019 yielded 2,959 records, 34 of which were screened on full-text. Observational studies and RCTs which tested the efficacy of MDMA, ketamine, LSD, or psilocybin for reducing PTSD symptoms in adults, and reported changes to PTSD diagnosis or symptomatology, were included. Nine trials (five ketamine and four MDMA) met inclusion criteria. Trials were rated on a quality and bias checklist and GRADE was used to rank the evidence. The evidence for ketamine as a stand-alone treatment for comorbid PTSD and depression was ranked "very low", and the evidence for ketamine in combination with psychotherapy as a PTSD treatment was ranked "low". The evidence for MDMA in combination with psychotherapy as a PTSD treatment was ranked "moderate".


Subject(s)
Ketamine , N-Methyl-3,4-methylenedioxyamphetamine , Stress Disorders, Post-Traumatic , Humans , Lysergic Acid Diethylamide/therapeutic use , N-Methyl-3,4-methylenedioxyamphetamine/therapeutic use , Psilocybin/therapeutic use , Psychotherapy , Psychotropic Drugs , Stress Disorders, Post-Traumatic/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL